Département de Cardiologie, Centre Hospitalier Universitaire Pontchaillou, 35033 Rennes cedex 09, France.
Eur J Heart Fail. 2009 Jul;11(7):699-705. doi: 10.1093/eurjhf/hfp074. Epub 2009 Jun 7.
In CARE-HF, cardiac resynchronization therapy (CRT) lowered morbidity and mortality in patients with moderate to severe heart failure. We examined whether baseline and follow-up electrocardiographic characteristics might predict long-term outcome.
CARE-HF randomly assigned 409 patients to medical therapy (MT) plus CRT, and 404 patients to MT alone. Electrocardiographic measurements were made at baseline during sinus rhythm, and at 3 months during paced or spontaneous rhythm depending on treatment assignment. Favourable outcome was defined as freedom from death, urgent transplantation, or cardiovascular hospitalization. Among patients assigned to CRT, 39% had unfavourable outcomes including 55 deaths. By single variable analysis, (i) prolonged PR interval, left QRS axis (but not QRS duration), and left bundle branch block (BBB) at baseline, and (ii) heart rate, PR, and QRS duration at 3 months predicted unfavourable outcome. By multiple variable analysis, treatment assignment (P = 0.0001), PR (P = 0.0004), and right BBB (P < 0.00013) at baseline predicted outcome, whereas baseline JTc and QRS duration at 3 months predicted all-cause mortality and heart failure hospitalization (P = 0.0071).
In CARE-HF, QRS duration at baseline did not predict outcome, but QRS at 3 months was a predictor by single variable analysis. Patients with prolonged PR interval and the 5% of patients with right BBB had a particularly high event rate.
在 CARE-HF 研究中,心脏再同步治疗(CRT)降低了中重度心力衰竭患者的发病率和死亡率。我们研究了基线和随访心电图特征是否可以预测长期预后。
CARE-HF 研究将 409 例患者随机分为 CRT 加药物治疗(MT)组,404 例患者为 MT 组。在窦性心律时进行基线心电图测量,根据治疗分组,在起搏或自主节律时进行 3 个月的随访心电图测量。良好的预后定义为无死亡、紧急移植或心血管住院。在 CRT 组中,39%的患者出现不良预后,包括 55 例死亡。单变量分析显示,(i)基线时 PR 间期延长、左 QRS 轴(但不是 QRS 时限)和左束支传导阻滞(BBB),以及(ii)3 个月时的心率、PR 和 QRS 时限均预测不良预后。多变量分析显示,治疗分组(P = 0.0001)、基线时的 PR(P = 0.0004)和右 BBB(P < 0.00013)预测预后,而基线时的 JTc 和 3 个月时的 QRS 时限预测全因死亡率和心力衰竭住院率(P = 0.0071)。
在 CARE-HF 研究中,基线 QRS 时限不预测预后,但 3 个月时的 QRS 时限是单变量分析的预测因素。PR 间期延长和 5%的患者存在右束支阻滞的患者事件发生率特别高。